| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,234 |
18,457 |
$1.62M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,336 |
15,910 |
$961K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,063 |
1,965 |
$166K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,495 |
2,344 |
$155K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,061 |
2,009 |
$150K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,718 |
8,376 |
$137K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
5,487 |
5,324 |
$122K |
| 36415 |
Collection of venous blood by venipuncture |
22,305 |
19,877 |
$86K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
978 |
952 |
$74K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,520 |
3,397 |
$71K |
| X5622 |
|
1,638 |
1,605 |
$47K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,590 |
1,518 |
$39K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
424 |
409 |
$32K |
| 99215 |
Prolong outpt/office vis |
336 |
316 |
$31K |
| 80061 |
Lipid panel |
1,610 |
1,571 |
$20K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
251 |
248 |
$20K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,210 |
1,178 |
$20K |
| 80053 |
Comprehensive metabolic panel |
1,806 |
1,712 |
$18K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
173 |
171 |
$17K |
| 96127 |
|
3,387 |
3,216 |
$14K |
| 99188 |
|
2,392 |
2,333 |
$14K |
| 90686 |
|
2,445 |
2,384 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
354 |
339 |
$12K |
| 99421 |
|
476 |
422 |
$11K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
288 |
286 |
$10K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,359 |
1,223 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,112 |
1,092 |
$10K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
259 |
257 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
251 |
248 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,243 |
1,142 |
$9K |
| 85027 |
|
1,447 |
1,382 |
$9K |
| 92551 |
|
1,826 |
1,778 |
$8K |
| 90715 |
|
462 |
443 |
$7K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
261 |
259 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
881 |
829 |
$7K |
| 0012A |
|
359 |
354 |
$7K |
| 0011A |
|
403 |
390 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
252 |
249 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
213 |
212 |
$6K |
| 99442 |
|
215 |
152 |
$6K |
| 90651 |
|
188 |
178 |
$5K |
| 86803 |
|
258 |
254 |
$4K |
| 99000 |
|
275 |
273 |
$4K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
94 |
93 |
$4K |
| 90682 |
|
58 |
57 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
345 |
340 |
$3K |
| 99443 |
|
70 |
46 |
$3K |
| 90670 |
|
1,332 |
1,279 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
71 |
63 |
$3K |
| 36416 |
|
936 |
704 |
$2K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
53 |
49 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
65 |
60 |
$2K |
| 84439 |
|
226 |
222 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
128 |
119 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
38 |
38 |
$2K |
| 86780 |
|
141 |
140 |
$2K |
| 99441 |
|
137 |
97 |
$2K |
| 81001 |
|
541 |
512 |
$2K |
| 87210 |
|
268 |
254 |
$2K |
| 99173 |
|
1,874 |
1,823 |
$1K |
| 99243 |
|
150 |
149 |
$1K |
| 90834 |
Psychotherapy, 45 minutes with patient |
20 |
14 |
$1K |
| 99460 |
|
30 |
29 |
$1K |
| 99422 |
|
26 |
25 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
191 |
174 |
$1K |
| 20610 |
|
28 |
28 |
$1K |
| 81025 |
|
141 |
139 |
$1K |
| 90473 |
|
57 |
57 |
$1K |
| 90474 |
|
116 |
114 |
$1K |
| 91320 |
|
13 |
13 |
$1K |
| 17110 |
|
12 |
12 |
$1K |
| 96161 |
|
605 |
587 |
$1K |
| 86140 |
|
191 |
184 |
$986.52 |
| 0064A |
|
30 |
29 |
$926.13 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
20 |
20 |
$884.58 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15 |
15 |
$676.96 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
421 |
401 |
$554.47 |
| 0134A |
|
15 |
15 |
$536.13 |
| 82728 |
|
37 |
36 |
$473.90 |
| 84702 |
|
27 |
25 |
$428.75 |
| 90480 |
|
14 |
14 |
$386.84 |
| 90656 |
|
42 |
42 |
$330.40 |
| 85652 |
|
114 |
110 |
$319.00 |
| 82043 |
|
40 |
39 |
$231.61 |
| 73630 |
|
13 |
12 |
$230.23 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
45 |
42 |
$182.52 |
| G0008 |
Administration of influenza virus vaccine |
53 |
52 |
$170.66 |
| 87186 |
|
25 |
24 |
$167.81 |
| 85610 |
|
36 |
25 |
$157.81 |
| 86850 |
|
12 |
12 |
$127.68 |
| 82950 |
|
12 |
12 |
$62.04 |
| 82248 |
|
12 |
12 |
$40.92 |
| 86900 |
|
12 |
12 |
$39.12 |
| 86901 |
|
12 |
12 |
$39.12 |
| 85018 |
|
12 |
12 |
$28.49 |
| 81003 |
|
14 |
14 |
$26.84 |
| 90744 |
|
510 |
480 |
$26.66 |
| 90681 |
|
178 |
168 |
$0.00 |
| 90633 |
|
674 |
653 |
$0.00 |
| 90685 |
|
179 |
155 |
$0.00 |
| 90734 |
|
114 |
108 |
$0.00 |
| 90700 |
|
14 |
13 |
$0.00 |
| 90707 |
|
53 |
52 |
$0.00 |
| 90648 |
|
12 |
12 |
$0.00 |
| 90710 |
|
26 |
24 |
$0.00 |
| 90698 |
|
941 |
889 |
$0.00 |
| 90680 |
|
139 |
139 |
$0.00 |
| 90696 |
|
63 |
61 |
$0.00 |
| 91301 |
|
28 |
28 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |